ITI Lifesciences to back ophthalmic delivery R&D
This article was originally published in Clinica
Executive Summary
ITI Lifesciences has invited companies looking to be in the vanguard of intraocular delivery (IOD) technologies to apply for a £5-10m ($10-20m) R&D commission.